… PA Jr, et al: Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus
cisplatin in the treatment of patients with advanced non-small-cell lung cancer: A Southwest …

… -blind, randomized phase III study tested the safety and efficacy of darbepoetin alfa
administered weekly for the treatment of anemia in patients with lung cancer receiving multicycle …

… lung cancer. Patients and Methods We conducted a multicenter, open-label, randomized …
to standard treatment in patients with newly diagnosed lung cancer of any stage and histology. …

… patients and the only agent for which phase III data exists in a large number of patients
with prior platinum therapy. In the first of two randomized phase III trials, median survival with …

… In a randomized phase III trial, 610 patients with inoperable stage II or III non–small cell
lung cancer were randomly assigned to two different concurrent regimens (chemotherapy with …

… , a placebo-controlled, double-blind, randomized phase II trial was designed to assess
the … line standard chemotherapy for treatment of extensive-stage small-cell lung cancer (SCLC). …

Purpose To evaluate the effect of BLP25 liposome vaccine (L-BLP25) on survival and
toxicity in patients with stage IIIB and IV non–small-cell lung cancer (NSCLC). Secondary …

… Lung cancer is the most common cancer in the world today (12.3% of all new cases), with …
deaths (17.8% of all cancer deaths) worldwide in 2000. Non—small-cell lung cancer (NSCLC) …

… cancer, breast cancer, renal carcinoma, and some malignant brain tumors. In ED-SCLC, a
recent randomized, placebo-controlled phase … intergroup, prospective, randomized phase II–III …

… phase II results of docetaxel monotherapy, this phase III trial was conducted of chemotherapy
for patients with advanced non–small-cell lung cancer … patients were randomized to receive …